Bluejay Investor Presentation Deck

Management & Advisors: Leadership, Diagnostic & Product Launch Expertise ●●● ●● Indranil "Neil" Dey CEO and Co-founder ● ● Involved in introducing Her2neu test for Herceptin Lead numerous global teams • Ph.D. in Biochemistry (UNESCO fellow) from BRC, Hungary, MBA (Fulbright Scholar) from Cambridge University, UK IMPATH The Cancer Information Company DIAGNOSTICS Kenneth Fisher Chief Financial Officer ● Responsible for Bluejay finance, investor relations, accounting and administrative operations • CPA: BA, Business Administration, Isenberg School of Management, UMass Amherst East Boston Savings Bank Jason Cook Chief Technology Officer ● ● •15+ years in POC/ diagnostics product development Responsible for Bluejay product development and manufacturing operations ● Ph.D. in Biomedical Engineering, University of Texas at Austin TEXAS The University of Texas at Austin Kevin Vance Chief Commercial Officer ● Responsible for Bluejay worldwide direct sales ● and strategic partnerships. • Prior Chief BD Executive for Vibra Healthcare BS, Industrial Engineering & Operations Research UMass Amherst; MBA, Western New England University YV VIBRA HEALTHCARE Mark Feinberg Chief Medical Advisor ● ● Guide Bluejay clinical development programs provide strategic medical and scientific leadership • Associate Professor, Harvard Medical School/Cardiovascular, Brigham & Women's; Medical College of Pennsylvania Brigham and Women's Hospital Founding Member, Mass General Brigham Copyright ©2022 Bluejay Diagnostics, Inc. All rights reserved in all slides | October 2022 12

View entire presentation